
Pelage Pharmaceuticals Secures $120 Million Funding for Regenerative Hair Therapy Development
Pelage Pharmaceuticals has raised $120 million in Series B financing to advance its novel hair restoration therapy PP405, which represents a significant step in translating stem cell science into practical regenerative medicine for the multi-billion dollar hair loss market.
Read full story

























